BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33624128)

  • 1. A tandem giant magnetoresistance assay for one-shot quantification of clinically relevant concentrations of N-terminal pro-B-type natriuretic peptide in human blood.
    Meng F; Huo W; Lian J; Zhang L; Shi X; Jesorka A; Gao Y
    Anal Bioanal Chem; 2021 May; 413(11):2943-2949. PubMed ID: 33624128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic Digital Immunoassay for Point-of-Care Detection of NT-proBNP from Whole Blood.
    Chen C; Porter R; Zhou X; Snozek CL; Yang EH; Wang S
    Anal Chem; 2024 Jul; 96(26):10569-10576. PubMed ID: 38877973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement Nt-proBNP circulating concentrations in heart failure patients with a new point-of-care assay.
    Lepoutre T; Rousseau MF; Ahn SA; Gruson D
    Clin Lab; 2013; 59(7-8):831-5. PubMed ID: 24133913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-Shot Full-Range Quantification of Multi-Biomarkers With Different Abundance by a Tandem Giant Magnetoresistance Assay.
    Meng F; Zhang L; Lian J; Huo W; Shi X; Gao Y
    Front Chem; 2022; 10():911795. PubMed ID: 35692686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Evaluation of Up-Converting Phosphor Technology-Based Lateral Flow Assay for Quantitative Detection of NT-proBNP in Blood.
    Yang X; Liu L; Hao Q; Zou D; Zhang X; Zhang L; Li H; Qiao Y; Zhao H; Zhou L
    PLoS One; 2017; 12(2):e0171376. PubMed ID: 28151978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Method for Blood NT-proBNP Determination Based on a Near-infrared Point of Care Testing Device with High Sensitivity and Wide Scope.
    Zhang XG; Shu YG; Gao J; Wang X; Liu LP; Wang M; Cao YX; Zeng Y
    Biomed Environ Sci; 2017 Jun; 30(6):426-431. PubMed ID: 28705266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].
    Wang WJ; Zhang XM; Wang Q; Wen DM; Ouyang NL; Cui YL; Li F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):695-9. PubMed ID: 22169413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the analytical performance characteristics of NT-proBNP immunoassay on dimension RxL-HM (Dade Behring)].
    Benoit MO; Dautezac F; Taccoen M; Paul JL
    Ann Biol Clin (Paris); 2005; 63(4):411-6. PubMed ID: 16061439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood.
    Zugck C; Nelles M; Katus HA; Collinson PO; Gaze DC; Dikkeschei B; Gurr E; Hayen W; Haass M; Hechler C; van Hoof V; Guerti K; van Waes C; Printzen G; Klopprogge K; Schulz I; Zerback R
    Clin Chem Lab Med; 2006; 44(10):1269-77. PubMed ID: 17032141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.
    Bruins S; Fokkema MR; Römer JW; Dejongste MJ; van der Dijs FP; van den Ouweland JM; Muskiet FA
    Clin Chem; 2004 Nov; 50(11):2052-8. PubMed ID: 15345664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.
    Foo JY; Wan Y; Schulz BL; Kostner K; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
    Clin Chem; 2013 Oct; 59(10):1523-31. PubMed ID: 23820130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
    Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
    Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.
    Verdú JM; Comín-Colet J; Domingo M; Lupón J; Gómez M; Molina L; Casacuberta JM; Muñoz MA; Mena A; Bruguera-Cortada J
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):613-9. PubMed ID: 22541282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
    Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
    Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
    Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea.
    Murray H; Cload B; Collier CP; Sivilotti ML
    CJEM; 2006 Jul; 8(4):251-8. PubMed ID: 17324304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.